APA (7th ed.) Citation

Martiadis, V., Pessina, E., Raffone, F., Martini, A., Di Vincenzo, M., Della Rocca, B., . . . Sampogna, G. (2025). Efficacy and Safety of Adjunctive Aripiprazole LAI or Paliperidone LAI for the Management of Patients Suffering from Bipolar I Disorder with Comorbid Obsessive-Compulsive Disorder. Journal of Clinical Medicine, 14(3), 954. https://doi.org/10.3390/jcm14030954

Chicago Style (17th ed.) Citation

Martiadis, Vassilis, Enrico Pessina, Fabiola Raffone, Azzurra Martini, Matteo Di Vincenzo, Bianca Della Rocca, Domenico De Berardis, Carlo Ignazio Cattaneo, and Gaia Sampogna. "Efficacy and Safety of Adjunctive Aripiprazole LAI or Paliperidone LAI for the Management of Patients Suffering from Bipolar I Disorder with Comorbid Obsessive-Compulsive Disorder." Journal of Clinical Medicine 14, no. 3 (2025): 954. https://doi.org/10.3390/jcm14030954.

MLA (9th ed.) Citation

Martiadis, Vassilis, et al. "Efficacy and Safety of Adjunctive Aripiprazole LAI or Paliperidone LAI for the Management of Patients Suffering from Bipolar I Disorder with Comorbid Obsessive-Compulsive Disorder." Journal of Clinical Medicine, vol. 14, no. 3, 2025, p. 954, https://doi.org/10.3390/jcm14030954.